» Articles » PMID: 28276481

Identification of Berberine As a Direct Thrombin Inhibitor from Traditional Chinese Medicine Through Structural, Functional and Binding Studies

Overview
Journal Sci Rep
Specialty Science
Date 2017 Mar 10
PMID 28276481
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Thrombin acts as a key enzyme in the blood coagulation cascade and represents a potential drug target for the treatment of several cardiovascular diseases. The aim of this study was to identify small-molecule direct thrombin inhibitors from herbs used in traditional Chinese medicine (TCM). A pharmacophore model and molecular docking were utilized to virtually screen a library of chemicals contained in compositions of traditional Chinese herbs, and these analyses were followed by in vitro bioassay validation and binding studies. Berberine (BBR) was first confirmed as a thrombin inhibitor using an enzymatic assay. The BBR IC value for thrombin inhibition was 2.92 μM. Direct binding studies using surface plasmon resonance demonstrated that BBR directly interacted with thrombin with a K value of 16.39 μM. Competitive binding assay indicated that BBR could bind to the same argartroban/thrombin interaction site. A platelet aggregation assay demonstrated that BBR had the ability to inhibit thrombin-induced platelet aggregation in washed platelets samples. This study proved that BBR is a direct thrombin inhibitor that has activity in inhibiting thrombin-induced platelet aggregation. BBR may be a potential candidate for the development of safe and effective thrombin-inhibiting drugs.

Citing Articles

Exosomes-transferred LINC00668 Contributes to Thrombosis by Promoting NETs Formation in Inflammatory Bowel Disease.

Zhang L, Zheng B, Bai Y, Zhou J, Zhang X, Yang Y Adv Sci (Weinh). 2023; 10(28):e2300560.

PMID: 37590310 PMC: 10558653. DOI: 10.1002/advs.202300560.


Directional screening and identification of potential cytotoxic components from by a combination of surface palsmon resonance and chromatography.

Zhou W, Wang M, Zhang A, Huang D, Guo H, Shen G Chin Herb Med. 2023; 15(2):329-336.

PMID: 37265758 PMC: 10230635. DOI: 10.1016/j.chmed.2022.06.008.


Berberine Decreases Thrombosis Potential Induced by a High-choline Diet by Inhibiting CutC Enzyme.

Qu H, Zhang Y, Shi J, Zhao Y, Gao J, Gao Z Curr Med Chem. 2023; 31(24):3844-3856.

PMID: 37226795 DOI: 10.2174/0929867330666230524142632.


Screening and characterization estrogen receptor ligands from (Royle) Johnst. affinity ultrafiltration LC-MS and molecular docking.

Zhu L, Ma S, Liu M, Li K, E S, Wang Z Front Plant Sci. 2022; 13:1012553.

PMID: 36420029 PMC: 9676231. DOI: 10.3389/fpls.2022.1012553.


The role of berberine in Covid-19: potential adjunct therapy.

Babalghith A, Al-Kuraishy H, Al-Gareeb A, De Waard M, Al-Hamash S, Jean-Marc S Inflammopharmacology. 2022; 30(6):2003-2016.

PMID: 36183284 PMC: 9526677. DOI: 10.1007/s10787-022-01080-1.


References
1.
Chen T, Wang J, Li C, Zhang W, Zhang L, An L . Nafamostat mesilate attenuates neuronal damage in a rat model of transient focal cerebral ischemia through thrombin inhibition. Sci Rep. 2014; 4:5531. PMC: 4078306. DOI: 10.1038/srep05531. View

2.
Thorstensson F, Kvarnstrom I, Musil D, Nilsson I, Samuelsson B . Synthesis of novel thrombin inhibitors. Use of ring-closing metathesis reactions for synthesis of P2 cyclopentene- and cyclohexenedicarboxylic acid derivatives. J Med Chem. 2003; 46(7):1165-79. DOI: 10.1021/jm021065a. View

3.
Chen S, Zhou G, Zhang X, Mao J, de The H, Chen Z . From an old remedy to a magic bullet: molecular mechanisms underlying the therapeutic effects of arsenic in fighting leukemia. Blood. 2011; 117(24):6425-37. PMC: 3123014. DOI: 10.1182/blood-2010-11-283598. View

4.
Lan J, Zhao Y, Dong F, Yan Z, Zheng W, Fan J . Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. J Ethnopharmacol. 2014; 161:69-81. DOI: 10.1016/j.jep.2014.09.049. View

5.
Mathews I, Tulinsky A . Active-site mimetic inhibition of thrombin. Acta Crystallogr D Biol Crystallogr. 1995; 51(Pt 4):550-9. DOI: 10.1107/S0907444994013132. View